Unveiling Opportunities in the Swine Vaccines Market


Overview and Scope
The swine vaccine refers to a preparation that is administered or injected in pigs to stimulate the immune response against a specific infectious agent.

Sizing and Forecast
The swine vaccines market size has grown strongly in recent years. It will grow from $2.01  billion in 2023 to $2.2  billion in 2024 at a compound annual growth rate (CAGR) of 9.6%.  The  growth in the historic period can be attributed to disease outbreaks, economic losses, government regulations, increased swine production.

The swine vaccines market size is expected to see strong growth in the next few years. It will grow to $3.17  billion in 2028 at a compound annual growth rate (CAGR) of 9.5%.  The growth in the forecast period can be attributed to emerging diseases and viral strains, globalization of swine industry, climate and environmental changes, biosecurity measures, market competition. Major trends in the forecast period include veterinary advancements, evolving disease patterns, global demand for protein, technological advancements, preventive healthcare focus..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Segmentation & Regional Insights
The swine vaccines market covered in this report is segmented –

1) By Product: Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA (Deoxyribonucleic Acid) Vaccines, Recombinant Vaccines
2) By Disease: Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Other Diseases
3) By Distribution Channel: Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies
4) By Application: Government Tender, Market Sales

North America was the largest region in the swine vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the swine vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8163&type=smp

Major Driver Impacting Market Growth
The rising prevalence of diseases in swine is expected to propel the swine vaccine market. Swine disease is any divergence from an organism’s normal structural or functional condition accompanied by a few signs and symptoms of diseases such as pseudorabies, influenza. The demand for swine vaccines is increasing due to the rising prevalence of diseases in swine and the need to protect pigs from infectious diseases. For instance, in August 2022, according to the report by the World Organization for Animal Health (WAHIS), a global database of animal health, more than 1,125,000 pigs and 36,000 wild boars have been affected by African Swine Fever (ASF) since January 2020 (data reported through INs and FURs), resulting in more than 1,960,000 animal losses. Therefore, the rising prevalence of diseases in swine is expected to drive the growth of the market.

Key Industry Players
Major companies operating in the swine vaccines market report are Merck & Co Inc., Boehringer Ingelheim Animal Health USA Inc., Elanco Animal Health Inc., Biogenesis Bago SA, Phibro Animal Health Corporation, KM Biologics Co. Ltd., Hipra Laboratories SA, Ceva Santé Animale SA, Zoetis Inc., Jinyu Bio-Technology Co. Ltd., China Animal Husbandry Industry Co. Ltd., Virbac SA, Harbin Veterinary Research Institute, Bioveta AS, Bimeda Holdings plc, Biovac Ltd., Heska Corporation, Hester Biosciences Limited, Hygieia Biological Laboratories, IDT Biologika GmbH, Inovio Pharmaceuticals Inc., Intervet Inc., Komipharm International Co. Ltd., Kyoritsu Seiyaku Corporation, Laboratorios Hipra SA, Lohmann Animal Health International, Nexvet Biopharma plc, Norbrook Laboratories Limited, Ouro Fino Saúde Animal SA, Prondil SA, Vaxxinova International BV, Vetoquinol SA, Veyx Pharma GmbH, Tianjin Ringpu Bio-Technology Co. Ltd.

The swine vaccines market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model